By Annemarie Gibson, a mother of two children 13 and 11 years old living with Type 1 diabetes. She lives in Mira Mesa.
As the mom of two children with Type 1 diabetes, I constantly worry: What if my husband and I lose our health coverage or can no longer afford the medicines they need because drug corporations raise the prices beyond our means?Our sons,
Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the Senate Finance Committee’s Principles for Drug Pricing Reform:
“The principles for drug pricing reform released by the Senate Finance Committee are a big step in the right direction and demonstrate that Chairman Wyden plans to prioritize patients,
The hefty price tag for Biogen’s new Alzheimer’s drug proves that when drug corporations have monopoly power to set prices, they will set them ridiculously high. Biogen is selling false hopes, rather than clinical results, to desperate families — but still stands to make a profit. Already since the announcement of the FDA’s approval, Biogen’s share price has skyrocketed.
By Emily Ingwersen, Special to the Press Herald
Thousands of Mainers and millions of Americans recently filed taxes. As a small-business owner, I probably think more about taxes than the average Mainer, and every tax day I find myself reflecting on all the important investments that taxes make possible in our communities.
President Joe Biden recently said: “Health care should be a right, not a privilege in America.” Having spent a lifetime navigating Florida’s patchwork of health coverage options and providers, I couldn’t agree more.
Nearly 40 years ago I gave birth while covered by Medicaid,
It’s appalling, but not surprising, that Johnson & Johnson is trying to get the conservative justices on the Supreme Court to let them off the hook. This is a company that knowingly and intentionally targeted African American women with a carcinogenic product that resulted in the development of life-threatening ovarian cancer.
For decades now, Americans have made clear that lowering the cost of prescription drugs is a key issue for them — and across party lines.
